文献速递腹部技术与安全PETCT

基于术前无创多模态18F-FDG PET/CT影像组学预测胃腺癌HER2表达

Prediction of HER2 Expression in Gastric Adenocarcinoma Based On Preoperative Noninvasive Multimodal 18F-FDG PET/CT Imaging.
PubMed 文献 · Acad Radiol · 2024-02-01

回顾性纳入133例胃腺癌患者(训练集93例、验证集40例),基于18F-FDG PET/CT多模态影像组学构建预测HER2表达的模型。综合模型整合7个临床特征、1个CT特征和5个PET特征,训练集AUC 0.95(95%CI 0.89-1.00),验证集AUC 0.76(95%CI 0.52-1.00),决策曲线净获益优于其他模型,校准曲线一致性良好,并构建列线图用于术前无创预测HER2表达。

要点

  • 综合模型训练集AUC 0.95(95%CI 0.89-1.00),验证集AUC 0.76(95%CI 0.52-1.00)。
  • 综合模型整合7个临床特征、1个CT特征和5个PET特征预测HER2表达。
  • 基于综合模型构建列线图,提供术前无创预测HER2表达的方法。

核心结论

  • 术前18F-FDG PET/CT多模态影像组学模型可有效预测胃腺癌患者的HER2表达,从而指导临床决策并推进精准医学领域。

研究设计与样本

  • 回顾性研究,纳入133例胃腺癌患者,按7:3分为训练集93例和验证集40例。

诊断标准与关键数值

  • 综合模型整合7个临床特征、1个CT特征和5个PET特征,训练集AUC 0.95(95%CI 0.89-1.00),验证集AUC 0.76(95%CI 0.52-1.00)。

临床应用与阅片要点

  • 综合模型在决策曲线上较其他模型表现出更优的净获益。
  • 综合模型在校准曲线上与观察值显示出良好的一致性。
  • 基于综合模型构建列线图,用于术前无创预测HER2表达。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: This study aims to investigate the role of a flourine-18 fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) multimodal radiomics model in predicting the status of human epidermal growth factor receptor 2 (HER2) expression preoperatively in cases of gastric adenocarcinoma.

MATERIALS AND METHODS: This retrospective study included 133 patients with gastric adenocarcinoma who were classified into training (n = 93) and validation (n = 40) cohorts in a ratio of 7:3. Features were selected using Least Absolute Shrinkage and Selection Operator and Extreme Gradient Boosting (XGBoost) methods; further, prediction models were constructed using logistic regression and XGBoost. These models were evaluated and validated using area under the curve (AUC), decision curves, and calibration curves to select the best-performing model.

RESULTS: Six different models were established to predict HER2 expression. Among these, the comprehensive model, which integrates seven clinical features, one CT feature, and five PET features, demonstrated AUC values of 0.95 (95% confidence interval [CI]: 0.89-1.00) and 0.76 (95% CI: 0.52-1.00) in the training and validation cohorts, respectively. Compared with other models, this model exhibited a superior net benefit on the decision curve and demonstrated good alignment agreement with the observed values on the calibration curve. Based on these findings, we constructed a nomogram for visualizing the model, providing a noninvasive preoperative method for predicting HER2 expression.

CONCLUSION: The preoperative 18F-FDG PET/CT multimodal radiomics model can effectively predict HER2 expression in patients with gastric adenocarcinoma, thereby guiding clinical decision-making and advancing the field of precision medicine.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Qin L, Chen W, Ye Y, et al. Prediction of HER2 Expression in Gastric Adenocarcinoma Based On Preoperative Noninvasive Multimodal 18F-FDG PET/CT Imaging. Acad Radiol. 2024. PMID: 38302386. doi:10.1016/j.acra.2024.01.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。